Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates☆
- 29 February 2000
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 36 (2) , 113-117
- https://doi.org/10.1016/s0732-8893(99)00117-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Use of an Isogenic Escherichia coli Panel To Design Tests for Discrimination of β-Lactamase Functional Groups of EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 1999
- Outbreak of Ceftazidime-Resistant Klebsiella pneumoniae in a Pediatric Hospital in Warsaw, Poland: Clonal Spread of the TEM-47 Extended-Spectrum β-Lactamase (ESBL)-Producing Strain and Transfer of a Plasmid Carrying the SHV-5-Like ESBL-Encoding GeneAntimicrobial Agents and Chemotherapy, 1998
- Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenes StrainsAntimicrobial Agents and Chemotherapy, 1998
- Further Occurrence of Extended-Spectrum β-Lactamase-Producing Salmonella enteritidisJournal of Chemotherapy, 1998
- Variability of chromosomally encoded beta-lactamases from Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1997
- Extended-spectrum ß-lactamases: Dilemmas in detection and therapyAntimicrobics and Infectious Diseases Newsletter, 1997
- Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical CenterClinical Infectious Diseases, 1996
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Extended-spectrum β-lactamase in Proteus mirabilisJournal of Antimicrobial Chemotherapy, 1994